RxDoctor Payments Data

Alyssa Tarburton, PA

Physician Assistant · Newark, DENPI 1407280977

Payments from drug & device makers

$1,974in general payments, 2019–2025

Across 108 payments — averaging $18.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$433
  • Novo Nordisk$380
  • Astellas Pharma US Inc$186
  • Pfizer$179
  • Lilly USA, LLC$168
  • Exact Sciences$134
  • plus $494 from 14 others

What the payments were for

  • Food & beverage$1,91397%
  • Education$613%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,974 in reported general payments places this provider in the 85th percentile of 527 physician assistant providers in Delaware.

See all physician assistant providers in Delaware

Medicare billing

Part B allowed, 2024
$37,128
Medicare patients
107
Services billed
510

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Nurtec OdtRimegepant Sulfate13$24,540
FarxigaDapagliflozin Propanediol13$21,089
MounjaroTirzepatide12$11,415
Fluoxetine Hcl25$989
Albuterol Sulfate HfaAlbuterol Sulfate12$813
Pravastatin Sodium21$767
Rosuvastatin Calcium39$767
Diltiazem 24hr Er (Cd)Diltiazem Hcl15$765
Bupropion XlBupropion Hcl17$727
Losartan Potassium44$633
Escitalopram Oxalate23$625
Atorvastatin Calcium64$495
Amlodipine Besylate55$461
Valsartan15$381
Levothyroxine Sodium39$344

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerNurtec Odt$179$24,54013 claims
AstraZenecaFarxiga$433$21,08913 claims
Lilly USA, LLCMounjaro$168$11,41512 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 527 physician assistant providers in Delaware.

Other physician assistant in Newark

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →